about
Ten putative contributors to the obesity epidemicImmediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adultsIs increased antidepressant exposure a contributory factor to the obesity pandemic?Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study.Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: a review for primary care physicians.Long-term body weight outcomes of antidepressant-environment interactionsAdverse endocrine and metabolic effects of psychotropic drugs: selective clinical review.Use of antidepressant medication and risk of type 2 diabetes: results from three cohorts of US adults.Bidirectional association between depression and obesity in middle-aged and older women.The prospective association between obesity and major depression in the general population: does single or recurrent episode matter?Is the Relationship between Common Mental Disorder and Adiposity Bidirectional? Prospective Analyses of a UK General Population-Based Study.From chlorpromazine to clozapine--antipsychotic adverse effects and the clinician's dilemma.The assessment and management of antipsychotic-associated metabolic disturbances from a psychiatric perspective.Schizophrenia, the metabolic syndrome and diabetes.Psychiatric medication-induced obesity: treatment options.Neuropsychiatric disorders at the presentation of type 2 diabetes mellitus in children.Antipsychotic-induced weight gain.Carbamazepine extended-release capsules: a new treatment option for bipolar I disorder.Medications associated with weight gain.Comparison of combinations of drugs for treatment of obesity: body weight and echocardiographic status.Weight gain in bipolar disorder: pharmacological treatment as a contributing factor.Obesity and psychotropics.Amantadine for olanzapine-induced weight gain: a systematic review and meta-analysis of randomized placebo-controlled trials.Weight considerations in psychotropic drug prescribing and switching.Sex differences in rates of obesity in bipolar disorder: postulated mechanisms.Managing comorbid obesity and depression through clinical pharmacotherapies.Do Anxiety Disorders Play a Role in Adolescent Obesity?Obese youths are not more likely to become depressed, but depressed youths are more likely to become obese.Childhood parental loss and bipolar spectrum in obese bariatric surgery candidates.Effects of fluoxetine and imipramine in rat fetuses treated during a critical gestational period: a macro and microscopic study.Investigation of antidepressant medication usage after bariatric surgery.Portal infusion of a selective serotonin reuptake inhibitor enhances hepatic glucose disposal in conscious dogs.Is hunger a driver of the cognitive development?No change of the lipid profile under the control of ApoE gene polymorphism in schizophrenics under paliperidone treatment.
P2860
Q24619245-36A44E5B-74EE-4D1F-8982-5A86CF989F7FQ26471999-8F24413B-C7A2-4F86-A839-C5AE6935DBBDQ26765430-FC1E62A3-2526-495E-B8B2-B2FF4E2CAD8AQ33186211-C0F6933D-BA20-40D6-9E15-A8C24706C7D8Q34033259-EE47CFB1-89CA-4A60-A347-2203A29EC0C3Q34153588-6434E785-77A7-4953-94BF-3863B4D9CEF3Q34614432-43FDEFDE-2DFF-4253-82FC-2DA4762BC9ABQ34631395-E9643915-8991-4088-ABDA-7A4645C708CCQ35600782-0EBA12E1-C25E-47E7-89DD-34FDE3D5079BQ35603995-7A52B8FD-BCB5-44C9-AA1F-B1B00A6838EAQ35620597-D833D4B4-1DE5-4218-A5CC-A263DBD2EE27Q35633701-D49C9B08-7463-4D02-BB53-FF1F1AE9B549Q35752734-C7F0D39D-E207-4CE0-B8AA-7F861BA9DE67Q35779054-E8256773-967F-40AF-8EC7-DDEDD4CD871CQ35905513-BAC5FBDB-87EE-4BD2-9C48-C011C26F92D9Q36166349-E237562C-6625-4DF1-8B6D-3D57ACD4BAA5Q36211002-872F2AEC-2DEB-4457-934A-C3B8FE3E7208Q36257188-8E426D60-E6E7-4DE9-A71F-0935599C64F0Q36309632-297CA141-B81B-44C4-8D9B-3319C1E37AA2Q36673903-D58F7A7F-9785-464F-9139-E934EBC9D182Q37171035-C1CBDFD5-AAA7-4760-BE5B-35E154BFD7A7Q37954390-2C0310CE-B4C7-461C-AF0B-64BDA4BFF0FBQ38132164-F96CC6A0-3655-418D-8ED3-03DFB0C3E78FQ38151453-795DB76E-B356-4A2F-9D65-9996A23BA204Q38182163-9F4D3193-17C2-4ED6-8AA4-434377A5C0DAQ38859885-85EAE41D-25BA-42EC-9A72-5769AB4041BEQ38897351-1A7BB4B1-5E27-4699-B95A-33EA1D5BF906Q39489662-978E1DEA-D0FC-4361-B885-2E7FC62B5EA3Q42605112-78199478-1635-46FA-BE8B-44769885AB1CQ43211986-036F8251-318D-4C47-AA52-035F5BE16B83Q44176317-E3105462-3906-4C52-B10F-5137E2021839Q45021671-54504B08-0D17-47E0-A397-FE216C205719Q48431226-8D7E70FC-5356-4CAE-B66D-0BCF9C097BAAQ51123490-EC67C851-E78E-4244-BD63-28EFF0B73FA7
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Effects of Nefazodone on Body Weight
@ast
Effects of Nefazodone on Body Weight
@en
type
label
Effects of Nefazodone on Body Weight
@ast
Effects of Nefazodone on Body Weight
@en
prefLabel
Effects of Nefazodone on Body Weight
@ast
Effects of Nefazodone on Body Weight
@en
P2093
P356
P1476
Effects of Nefazodone on Body Weight
@en
P2093
David L. Ginsberg
Jessica Bikoff
Norman Sussman
P304
P356
10.4088/JCP.V62N0407
P577
2001-04-15T00:00:00Z